Melt&Marble Announces Commercial Launch of Marble7®, a Precision-Fermented Bioactive Lipid for Personal Care

• Marble7® is Melt&Marble’s first commercially available personal care ingredient.

• A new collaboration with Covalo will make the ingredient easier for beauty and personal care formulators to discover, evaluate and sample.

• Melt&Marble showcased its 3-in-1 bioactive lipid in the Innovation Zone at in-cosmetics Korea.

  
  

GOTHENBURG, SWEDEN — 15 July 2026 — Swedish precision fermentation company Melt&Marble, which develops designer fats and lipids for food and personal care, has announced the commercial launch of Marble7®, its first precision-fermented lipid ingredient for the personal care market, which debuted at in-cosmetics Korea last week.

Marble7®, which received the INCI name r-Saccharomyces Butter in March, is a 3-in-1 bioactive lipid designed for use in skincare, makeup and hair care formulations.

As beauty brands look for ingredients that combine performance, sensorial appeal and more resilient sourcing, lipid innovation is becoming an increasingly important area of formulation development. Marble7® has been designed to help formulators meet these demands through a single precision-fermented lipid ingredient.

Designed for use across personal care applications, Marble7® supports several formulation needs. It offers a biomimetic skin lipid profile and is rich in Omega-7 and other bioactives for skin barrier-focused formulations. It also provides structure, stability, and sensorial performance, including a melt-on-contact transition to a smooth, silky skin feel and glide on multicategory applications. Together, these attributes allow formulators to explore alternatives to conventional plant-, animal- or petrochemical-derived lipid ingredients while maintaining a focus on performance, consistency and sensory appeal.

The launch marks an important commercial milestone for Melt&Marble as it expands beyond food applications into personal care. 

“Marble7® is our first commercial product for personal care and an important step in bringing precision-fermented designer lipids into real formulation use,” said Thomas Cresswell, Chief Business Officer at Melt&Marble. “For formulators, the opportunity is not only to replace existing lipid ingredients, but to access next-generation ingredients designed with specific performance, sensory and supply-chain needs in mind.”

Melt&Marble uses precision fermentation to produce fats and lipids with targeted structural and performance characteristics for use in the food and personal care industries. This approach enables the company to control aspects such as fatty acid profile, structure and melting behaviour.

Alongside the launch, Melt&Marble has entered into a collaboration with Covalo, a digital ingredient discovery platform, to expand Marble7®’s visibility across the global formulation community and support faster evaluation by product development teams. Covalo’s platform will enhance product visibility and simplify access to technical documentation, formulation concepts and samples for evaluation.

“This collaboration with Covalo allows us to move beyond traditional availability and actively drive adoption through digital activation, product visibility, and sample accessibility,” said Juliana Mancini Gomiero, Head of Business Development for Personal Care at Melt&Marble.

Yann Chilvers, Covalo CEO, said, “After watching Melt&Marble’s innovation and rapid development from the sideline, we are delighted to help the team accelerate their journey and add Marble7® to Covalo’s portfolio of ingredients. Melt&Marble’s precision fermentation ingredients answer a true need in the industry!".

Marble7® is commercially available from early July 2026. Formulators can discover the ingredient through Covalo or request further information directly from MeltandMarble.com .